NCT07449793 Biochemical Response and Clinical Outcomes in Patients With PBC Status RECRUITING Phase N/A
NCT07424677 Study of Saroglitazar Magnesium for PBC Patients With Incomplete Response or Intolerant to UDCA Therapy Status NOT_YET_RECRUITING Phase PHASE3
NCT07319169 The Value of Spleen Stiffness Measurement in Patients With PBC Status NOT_YET_RECRUITING Phase NA
NCT07282353 A Study of CS0159 in Patients With PBC With Inadequate Response or Intolerance to UDCA Status RECRUITING Phase PHASE3
NCT07216235 Long-Term Study to Evaluate the Safety and Efficacy in Participants With Primary Biliary Cholangitis of Saroglitazar Magnesium-V on Clinical Outcomes Status NOT_YET_RECRUITING Phase PHASE3
NCT07122206 Monitoring the Response of Combination Ursodiol and Seladelpar Treatment Status NOT_YET_RECRUITING Phase N/A
NCT07049887 A Study Describing Scratch and Sleep Patterns in Patients With Primary Biliary Cholangitis (Luminaria) Status COMPLETED Phase N/A
NCT06888115 A Study of the Pharmacokinetics and Safety of CS0159 in Subjects With Hepatic Injury Status COMPLETED Phase PHASE1
NCT06733519 TH104 for the Treatment of Pruritus in Primary Biliary Cholangitis Status NOT_YET_RECRUITING Phase PHASE2
NCT06730061 A Study of Elafibranor in Adult Japanese Participants With Primary Biliary Cholangitis (PBC) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06525311 A Study to Evaluate the Pharmacokinetics and Safety of K-808 (Pemafibrate) in Subjects With Primary Biliary Cholangitis With Compensated Cirrhosis and Without Cirrhosis. Status COMPLETED Phase PHASE1
NCT06488911 To Evaluate Safety and Tolerability of the Fixed- Dose Combination of Obeticholic Acid and Bezafibrate Status TERMINATED Phase PHASE3
NCT06447168 A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in Participants With Primary Biliary Cholangitis Who Are Receiving Ongoing Treatment Status RECRUITING Phase N/A
NCT06427395 Open-Label Extension Study of Saroglitazar Magnesium in Participants With Primary Biliary Cholangitis Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06417398 Preliminary Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune Diseases Status NOT_YET_RECRUITING Phase EARLY_PHASE1
NCT06383403 A Study of Elafibranor in Adults With Primary Biliary Cholangitis and Inadequate Response or Intolerance to Ursodeoxycholic Acid. Status ACTIVE_NOT_RECRUITING Phase PHASE3